Portfolio – Sound Shore Fund
January | 2017 | NEW LOW OBSERVER
Teva Pharmaceuticals - Recent News & Activity
Digging Into Berkshire Hathaway's Portfolio | Morningstar
TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Letters to the Morning Star (@letters2thestar) / X
Digging Into Berkshire Hathaway's Portfolio | Morningstar
/s3.amazonaws.com/arc-authors/morningstar/31856901-1aad-4d9c-b089-5282ccb35510.jpg "Reiterating Our No-Moat and Stable Trend Rating for Teva Due to Commoditization in U.S. Market | Morningstar")
Reiterating Our No-Moat and Stable Trend Rating for Teva Due to Commoditization in U.S. Market | Morningstar
Teva Pharmaceutical Industries Limited: TEVA Stock Quotes and Prices | US8816242098 | MarketScreener
TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Teva Stock: What We Know, And Don't, About The Adderall Shortage | Investor's Business Daily
Digging Into Berkshire Hathaway's Portfolio | Morningstar
TEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up - February 1, 2024 - Zacks.com
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
/s3.amazonaws.com/arc-authors/morningstar/b76d1412-e5af-4b94-8222-8cb66fe23dbe.jpg "Teva Doubles Down on Innovative Drugs and Partners With Sanofi to Codevelop Bowel Disease Drug | Morningstar")
Teva Doubles Down on Innovative Drugs and Partners With Sanofi to Codevelop Bowel Disease Drug | Morningstar
Digging Into Berkshire Hathaway's Portfolio | Morningstar
TEVA: Teva Pharmaceutical I...
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Morningstar Funds Trust Form N-CSRS Filed 2022-12-27
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Current Teva Pharmaceutical Industries dividend in February 2024
Teva Is The Drug Industry's Comeback Story (NYSE:TEVA) | Seeking Alpha
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd
Our Outlook for the Credit Markets | Morningstar
Teva Stock Dives After Inking $1.5 Billion Deal For Inflammation Drug | Investor's Business Daily
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals says production largely unaffected by Israel-Hamas conflict, raises guidance | NASDAQ:TEVA
